DE69825888D1 - Diagnostisches verfahren der alzheimer-erkrankung - Google Patents

Diagnostisches verfahren der alzheimer-erkrankung

Info

Publication number: DE69825888D1
Authority: DE; Germany
Prior art keywords: alzheimer; disease; diagnostic procedure; diagnostic; procedure
Prior art date: 1997-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69825888T

Other languages

English (en)

Other versions

DE69825888T2 (de

Inventor

Marie-Christin Chartier-Harlin

Jean-Charles Lambert

Philippe Amouyel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institut Pasteur de Lille

Institut National de la Sante et de la Recherche Medicale INSERM

Original Assignee

Institut Pasteur de Lille

Institut National de la Sante et de la Recherche Medicale INSERM

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-30

Publication date

2004-09-30

1998-06-30 Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille

2004-09-30 Publication of DE69825888D1 publication Critical patent/DE69825888D1/de

2005-11-17 Application granted granted Critical

2005-11-17 Publication of DE69825888T2 publication Critical patent/DE69825888T2/de

2018-07-01 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Analytical Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69825888T 1997-07-01 1998-06-30 Diagnostisches verfahren der alzheimer-erkrankung Expired - Lifetime DE69825888T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9708284A FR2765591B1 (fr)	1997-07-01	1997-07-01	Procede de diagnostic de la maladie d'alzheimer
FR9708284		1997-07-01
PCT/FR1998/001394 WO1999001574A1 (fr)	1997-07-01	1998-06-30	Procede de diagnostic de la maladie d'alzheimer

Publications (2)

Publication Number	Publication Date
DE69825888D1 true DE69825888D1 (de)	2004-09-30
DE69825888T2 DE69825888T2 (de)	2005-11-17

Family

ID=9508696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69825888T Expired - Lifetime DE69825888T2 (de)	1997-07-01	1998-06-30	Diagnostisches verfahren der alzheimer-erkrankung

Country Status (8)

Country	Link
US (1)	US6391553B1 (de)
EP (1)	EP0983391B1 (de)
JP (1)	JP4358311B2 (de)
AU (1)	AU8346498A (de)
CA (1)	CA2295865C (de)
DE (1)	DE69825888T2 (de)
FR (1)	FR2765591B1 (de)
WO (1)	WO1999001574A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6228610B1 (en) *	1993-09-20	2001-05-08	Novartis Corporation	Human metabotropic glutamate receptor subtypes (hmR4, hmR6, hmR7) and related DNA compounds
EP1113081A1 (de) *	1999-12-28	2001-07-04	Institut Pasteur De Lille	Zusammenhang des bekannten Gens CP2/LSF/LBP-1 mit Alzheimer
PT1529116E (pt) *	2002-08-07	2009-09-10	Novartis Ag	Métodos para o tratamento da demência com base no genótipo da apo e
JP5241994B2 (ja)	2004-11-05	2013-07-17	戸田工業株式会社	酸化チタン粒子粉末及び光触媒
US20060228728A1 (en) *	2005-01-31	2006-10-12	Perlegen Sciences, Inc.	Genetic basis of Alzheimer's disease and diagnosis and treatment thereof
EP1910569A4 (de) *	2005-06-17	2009-08-05	Genizon Biosciences Inc	Genkarte der mit langlebigkeit assoziierten menschlichen gene
CN103409511A (zh) *	2009-07-03	2013-11-27	加的夫大学学院咨询有限公司	阿尔茨海默病的诊断和治疗
WO2011024035A1 (en) *	2009-08-27	2011-03-03	Institut Pasteur De Lille	Method for determining the risk of occurrence of alzheimer's disease
US20150025077A1 (en)	2012-02-29	2015-01-22	Coyote Pharmaceuticals, Inc.	Gga and gga derivatives compositions thereof and methods for treating neurodegenerative diseases including paralysis including them
US9119808B1 (en)	2012-10-08	2015-09-01	Coyote Pharmaceuticals, Inc.	Treating neurodegenerative diseases with GGA or a derivative thereof
US20140178877A1 (en) *	2012-12-20	2014-06-26	Roche Molecular Systems, Inc.	Labeled Oligonucleotide Probes Used for Nucleic Acid Sequence Analysis
CA2978442A1 (en) *	2015-03-04	2016-09-09	Veracyte, Inc.	Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ257215A (en) *	1992-10-13	1996-12-20	Univ Duke	Diagnosis or prognosis of alzheimers using the presence of apolipoprotein e type 4 as an indicator and apolipoprotein e isoform specific antibodies
CA2111503A1 (en) *	1993-12-15	1995-06-16	Mcgill University	Apolipoprotein e polymorphism and alzheimer's disease
FR2716894B1 (fr) *	1994-03-07	1996-05-24	Pasteur Institut	Marqueurs génétiques utilisés conjointement pour le diagnostic de la maladie d'Alzheimer, méthode et kit de diagnostic.
GB9408465D0 (en) *	1994-04-27	1994-06-22	Univ Mcgill	Apolipoprotein e polymorphism & treatment of alzheimer's disease

1997
- 1997-07-01 FR FR9708284A patent/FR2765591B1/fr not_active Expired - Fee Related
1998
- 1998-06-30 WO PCT/FR1998/001394 patent/WO1999001574A1/fr active IP Right Grant
- 1998-06-30 AU AU83464/98A patent/AU8346498A/en not_active Abandoned
- 1998-06-30 US US09/446,893 patent/US6391553B1/en not_active Expired - Fee Related
- 1998-06-30 JP JP50652799A patent/JP4358311B2/ja not_active Expired - Fee Related
- 1998-06-30 EP EP98933758A patent/EP0983391B1/de not_active Expired - Lifetime
- 1998-06-30 DE DE69825888T patent/DE69825888T2/de not_active Expired - Lifetime
- 1998-06-30 CA CA2295865A patent/CA2295865C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2295865C (fr)	2012-09-04
JP2002510975A (ja)	2002-04-09
DE69825888T2 (de)	2005-11-17
WO1999001574A1 (fr)	1999-01-14
FR2765591A1 (fr)	1999-01-08
AU8346498A (en)	1999-01-25
FR2765591B1 (fr)	2002-08-09
CA2295865A1 (fr)	1999-01-14
EP0983391B1 (de)	2004-08-25
US6391553B1 (en)	2002-05-21
JP4358311B2 (ja)	2009-11-04
EP0983391A1 (de)	2000-03-08

Publication	Publication Date	Title
CY2018020I2 (el)	2019-07-10	Θεραπεια της νοσου ρομρε
FI951701L (fi)	1995-04-10	Menetelmät Alzheimerin taudin tunnistamiseksi
NO981388L (no)	1998-09-28	Bedring av Dupuytrens sykdom
DE69528011D1 (de)	2002-10-10	Verfahren zur Pflege der Nägel
NO953262D0 (no)	1995-08-18	Bedring av Dupuytrens sykdom
NO20001869D0 (no)	2000-04-11	Fremgangsmõte for behandling av Alzheimerssykdom
DE69825888D1 (de)	2004-09-30	Diagnostisches verfahren der alzheimer-erkrankung
DE69826951D1 (de)	2004-11-18	Verfahren zur Gewebepflege
TR199701051A3 (tr)	1999-03-22	2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
HUP0003684A3 (en)	2003-04-28	Diagnostic test for alzheimer's disease
NO982233L (no)	1996-04-22	Diagnostisk avbildningsmiddel
FR2725023B1 (fr)	1997-01-31	Diagnostic direct d'haptenes
DE69712899D1 (de)	2002-07-04	Diagnose von präe-eklampsie
GB9717142D0 (en)	1997-10-22	Diagnosis of alzheimer's disease
ITMI981834A0 (it)	1998-08-04	Diagnosi dell'autismo
GB9323826D0 (en)	1994-01-05	Diagnosis of alzheimer's disease
GB9418854D0 (en)	1994-11-09	Diagnosis of alzheimer's disease
UA25492A (uk)	1998-12-25	Спосіб лікуваhhя хвороби гіршпруhга
UA25468A (uk)	1998-12-25	Спосіб визhачеhhя життєздатhості м'язової ткаhиhи
GB9517266D0 (en)	1995-10-25	Diagnosis of alzheimer's disease
GB9709416D0 (en)	1997-07-02	Methods for treatment of alzheimer's disease using azaspiranes
LV12282A (lv)	1999-06-20	Panemiens galvas smadzenu saslimsanu diferencialajai diagnostikai
UA1629S (uk)	1997-10-31	Набір фестонів "веснянка-5"
SE9901466D0 (sv)	1999-04-23	Nucleic acids for diagnosing and modeling alzheimer's disease
KR980000689U (ko)	1998-03-30	목욕용 때밀이구

Legal Events

Date	Code	Title	Description
2005-09-22	8364	No opposition during term of opposition